Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol: A Randomised, Controlled Study versus Twice-Daily Tramadol in Patients with Osteoarthritis of the Knee

By Gérald Mongin  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 545-558

Adis International

Access to resources Recommend Favorite

Once-Daily Nebivolol 5mg Does Not Reduce Airway Patency in Patients with Chronic Obstructive Pulmonary Disease and Arterial Hypertension: A Placebo-Controlled Crossover Study

By dal Negro R.W.   Tognella S.   Pomari C.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 361-367

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Valsartan 160mg/Hydrochlorothiazide 25mg Combination in Patients with Hypertension not Adequately Controlled by Valsartan 160mg/Hydrochlorothiazide 12.5mg

By Peter Trenkwalder  

Clinical Drug Investigation, Vol. 24, Iss. 10, 2004-01 ,pp. : 593-602

Adis International

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite